Μ-Opioid Receptor Activation Directly Modulates Intrinsically Photosensitive Retinal Ganglion Cells. (1st June 2019)
- Record Type:
- Journal Article
- Title:
- Μ-Opioid Receptor Activation Directly Modulates Intrinsically Photosensitive Retinal Ganglion Cells. (1st June 2019)
- Main Title:
- Μ-Opioid Receptor Activation Directly Modulates Intrinsically Photosensitive Retinal Ganglion Cells
- Authors:
- Cleymaet, Allison M.
Gallagher, Shannon K.
Tooker, Ryan E.
Lipin, Mikhail Y.
Renna, Jordan M.
Sodhi, Puneet
Berg, Daniel
Hartwick, Andrew T.E.
Berson, David M.
Vigh, Jozsef - Abstract:
- Abstract: Intrinsically photosensitive retinal ganglion cells (ipRGCs) encode light intensity and trigger reflexive responses to changes in environmental illumination. In addition to functioning as photoreceptors, ipRGCs are post-synaptic neurons in the inner retina, and there is increasing evidence that their output can be influenced by retinal neuromodulators. Here we show that opioids can modulate light-evoked ipRGC signaling, and we demonstrate that the M1, M2 and M3 types of ipRGCs are immunoreactive for μ-opioid receptors (MORs) in both mouse and rat. In the rat retina, application of the MOR-selective agonist DAMGO attenuated light-evoked firing ipRGCs in a dose-dependent manner (IC50 < 40 nM), and this effect was reversed or prevented by co-application of the MOR-selective antagonists CTOP or CTAP. Recordings from solitary ipRGCs, enzymatically dissociated from retinas obtained from melanopsin-driven fluorescent reporter mice, confirmed that DAMGO exerts its effect directly through MORs expressed by ipRGCs. Reduced ipRGC excitability occurred via modulation of voltage-gated potassium and calcium currents. These findings suggest a potential new role for endogenous opioids in the mammalian retina and identify a novel site of action—MORs on ipRGCs—through which opioids might exert effects on reflexive responses to environmental light. Highlights: In the rodent retina M1-M3 types of intrinsically photosensitive ganglion cells (ipRGCs) express μ-opioid receptors (MORs).Abstract: Intrinsically photosensitive retinal ganglion cells (ipRGCs) encode light intensity and trigger reflexive responses to changes in environmental illumination. In addition to functioning as photoreceptors, ipRGCs are post-synaptic neurons in the inner retina, and there is increasing evidence that their output can be influenced by retinal neuromodulators. Here we show that opioids can modulate light-evoked ipRGC signaling, and we demonstrate that the M1, M2 and M3 types of ipRGCs are immunoreactive for μ-opioid receptors (MORs) in both mouse and rat. In the rat retina, application of the MOR-selective agonist DAMGO attenuated light-evoked firing ipRGCs in a dose-dependent manner (IC50 < 40 nM), and this effect was reversed or prevented by co-application of the MOR-selective antagonists CTOP or CTAP. Recordings from solitary ipRGCs, enzymatically dissociated from retinas obtained from melanopsin-driven fluorescent reporter mice, confirmed that DAMGO exerts its effect directly through MORs expressed by ipRGCs. Reduced ipRGC excitability occurred via modulation of voltage-gated potassium and calcium currents. These findings suggest a potential new role for endogenous opioids in the mammalian retina and identify a novel site of action—MORs on ipRGCs—through which opioids might exert effects on reflexive responses to environmental light. Highlights: In the rodent retina M1-M3 types of intrinsically photosensitive ganglion cells (ipRGCs) express μ-opioid receptors (MORs). Light-evoked firing of ipRGCs is attenuated by the MOR-specific agonist DAMGO in a dose-dependent manner. MOR activation reduces ipRGC excitability by modulating IK and reducing the amplitude of non-inactivating ICa . These findings suggest a potential new role for endogenous opioids in the mammalian retina. … (more)
- Is Part Of:
- Neuroscience. Volume 408(2019)
- Journal:
- Neuroscience
- Issue:
- Volume 408(2019)
- Issue Display:
- Volume 408, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 408
- Issue:
- 2019
- Issue Sort Value:
- 2019-0408-2019-0000
- Page Start:
- 400
- Page End:
- 417
- Publication Date:
- 2019-06-01
- Subjects:
- AC adenylate cyclase -- 4-AP 4-Aminopyridine -- BLA basolateral amygdala -- IK(Ca) calcium-dependent potassium currents -- CGP54626 [S-(R*, R*)]-[3-[[1-(3, 4-Dichlorophenyl)ethyl]amino-2-hydroxypropyl], (cyclohexylmethyl) phosphinic acid -- CTOP H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 CTAP, H-D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 -- DAMGO [D-Ala2, MePhe4, Gly-ol5]-enkephalin -- D-AP5 D-(−)-2-Amino-5-phosphonopentanoic acid -- D-AP7 D-(−)-2-Amino-7-phosphonoheptanoic acid -- EGFP enhanced green fluorescent protein -- GAD glutamic acid decarboxylase -- GCL ganglion cell layer -- GIRK G-protein-activated inwardly rectifying K+ channels -- IC50 half-blocking concentration -- V0.5 half-activation potential -- HEPES 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid -- INL inner nuclear layer -- IPL inner plexiform layer -- ipRGCs intrinsically photosensitive retinal ganglion cells -- L-AP4 L-(+)-2-Amino-4-phosphonobutyric acid -- LJP liquid junction potential -- Vm membrane potential -- MEA multielectrode array -- MOR μ-opioid receptor -- NBQX 2, 3-Dioxo-6-nitro-1, 2, 3, 4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide -- ONL outer nuclear layer -- OPL outer plexiform layer -- Rs series resistance -- TPMPA (1, 2, 5, 6-Tetrahydropyridin-4-yl) methylphosphinic acid -- TTX tetrodotoxin -- Cav voltage-gated calcium channel -- ICa voltage-gated calcium current -- Kv voltage-gated potassium channel -- IK voltage-gated potassium current -- INa voltage-gated sodium current -- V0.05 command voltage at which the resulting IK was 5% of the peak
opioids -- retina -- intrinsically photosensitive ganglion cell
Neurochemistry -- Periodicals
Neurophysiology -- Periodicals
Neurology -- Periodicals
Neurochimie -- Périodiques
Neurophysiologie -- Périodiques
Neurochemistry
Neurophysiology
Electronic journals
Periodicals
Electronic journals
612.8 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03064522 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/03064522 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/03064522 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuroscience.2019.04.005 ↗
- Languages:
- English
- ISSNs:
- 0306-4522
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.559000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10741.xml